Matches in Nanopublications for { ?s ?p "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909921.RADscI6X5IVCdBEazYqo-sdj6E5xJlGgCmDLAK0DkRXSs130_provenance.
- NP925995.RAk0afSaXE-jXndvHCz4AYqiBcF7Q6fSpGcTgFSVE2iYo130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925995.RAk0afSaXE-jXndvHCz4AYqiBcF7Q6fSpGcTgFSVE2iYo130_provenance.
- NP935055.RAAl03YIWvIP4hBKxlloMr1Qs38i8whzkxWd2Fy7lLUcg130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935055.RAAl03YIWvIP4hBKxlloMr1Qs38i8whzkxWd2Fy7lLUcg130_provenance.
- NP479000.RAisuOcfoaOwpiREzP7Ek1k8Pr3oAyRBxKOuLPQ5XLDqg130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479000.RAisuOcfoaOwpiREzP7Ek1k8Pr3oAyRBxKOuLPQ5XLDqg130_provenance.
- NP485038.RA_-7Ukk6zl-dHH6KwJbM9EojluRmv5ZP_AETUWDfrSCE130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485038.RA_-7Ukk6zl-dHH6KwJbM9EojluRmv5ZP_AETUWDfrSCE130_provenance.
- NP620455.RAl812LKeYLkmup80FU1bjGnuhOnIzZjsdCCOBhfr0S8g130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620455.RAl812LKeYLkmup80FU1bjGnuhOnIzZjsdCCOBhfr0S8g130_provenance.
- NP311832.RAOO1JkWozh5vlmEMFH1CQ_xJIfruxCmJu0xjBS3ZBvqo130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311832.RAOO1JkWozh5vlmEMFH1CQ_xJIfruxCmJu0xjBS3ZBvqo130_provenance.
- NP239483.RAVwyXL8YbmzDswkvLzBpsaxLXxnPS-_HNlKpzTddH1PM130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239483.RAVwyXL8YbmzDswkvLzBpsaxLXxnPS-_HNlKpzTddH1PM130_provenance.
- NP239606.RAW7iPYFu6xMSkvNDdrqcPdaNkLUglNxc9ojsFUL1XN_Y130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239606.RAW7iPYFu6xMSkvNDdrqcPdaNkLUglNxc9ojsFUL1XN_Y130_provenance.
- NP645427.RAyJKtak2KLOd4r1mKa5yXgz6bCSlJLGykGekirsbnldM130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645427.RAyJKtak2KLOd4r1mKa5yXgz6bCSlJLGykGekirsbnldM130_provenance.
- NP410320.RAS7z5xkF2k2-orL407_r4CVJIR2rEwRQ944OEZ4PvejE130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410320.RAS7z5xkF2k2-orL407_r4CVJIR2rEwRQ944OEZ4PvejE130_provenance.
- NP239691.RAvCLlxsacegY5AxLfGWLwNSKF4F5GPwCdp0AeVKh5EHY130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239691.RAvCLlxsacegY5AxLfGWLwNSKF4F5GPwCdp0AeVKh5EHY130_provenance.
- NP239437.RAD3uWvlD5sCSCTeS-P-NGnAsK8Lwhpdeg1mfUHkA_LOA130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239437.RAD3uWvlD5sCSCTeS-P-NGnAsK8Lwhpdeg1mfUHkA_LOA130_provenance.
- NP870769.RAImRG0GVZv8Kj5fbB71Oej2YJTK-zv1dHbPw86NADNqs130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870769.RAImRG0GVZv8Kj5fbB71Oej2YJTK-zv1dHbPw86NADNqs130_provenance.
- NP410318.RA5tRKH4jCKEY91980cy9QPvxsfM7XLCP8Vhj1LABF39I130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410318.RA5tRKH4jCKEY91980cy9QPvxsfM7XLCP8Vhj1LABF39I130_provenance.
- NP410319.RA50EANlmLEoqYDXviv7RFPYumsMbHdM5z-LhHdUZGiGc130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410319.RA50EANlmLEoqYDXviv7RFPYumsMbHdM5z-LhHdUZGiGc130_provenance.
- NP410321.RA-SHQerrrLnSzn5jMOfv3W-Br1I_NKSQ49ydgnI6q1LY130_assertion description "[In experiments to identify molecules that might be important in the pathogenesis of glioblastoma multiforme, the most common malignant brain tumor, we found that annexin II (Lipocortin 2, p36), a likely second messenger in several different mitogenic pathways, was highly expressed in tumor tissue of glioblastoma multiforme (9 of 9) and highly anaplastic astrocytoma (2 of 6), but not in astrocytomas of lower pathological grade (0 of 6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410321.RA-SHQerrrLnSzn5jMOfv3W-Br1I_NKSQ49ydgnI6q1LY130_provenance.